Carpal tunnel syndrome (CTS) is one of the most common peripheral nerve entrapment conditions encountered in clinical practice. Characterized by compression of the median nerve at the wrist, CTS can cause pain, paraesthesia, sensory disturbances, and impaired hand function, significantly affecting daily activities, sleep, and occupational performance.
Despite its prevalence, considerable variation remains in the assessment and conservative management of CTS, particularly regarding diagnostic testing, orthotic interventions, manual therapy, exercise, and the use of electrophysical agents.
The 2026 Clinical Practice Guideline (CPG) by Erickson et al., published in the Journal of Orthopaedic & Sports Physical Therapy, updates the previous 2019 recommendations by incorporating new research on examination procedures, outcome measures, and nonsurgical interventions.
This article summarizes the key recommendations through a physiotherapist’s lens, highlights their clinical implications and the most important changes since the 2019 guideline.
Treatment decisions should integrate the available evidence with symptom severity, neurological findings, patient preferences, and functional demands.
Why This Guideline Matters
Developed through a collaboration between the American Physical Therapy Association (APTA) Orthopedics and APTA Hand and Upper Extremity, the 2026 CPG provides an updated evidence-based framework for the assessment and rehabilitation of individuals with CTS. The guideline focuses primarily on classic CTS involving median nerve compression at the wrist, with treatment recommendations directed toward nonsurgical management. Consequently, these findings should not automatically be generalized to postoperative rehabilitation following carpal tunnel release. The development process included systematic literature reviews, independent assessment of study quality, consensus-based recommendations, and external review by clinical experts and consumer representatives. An important feature of this revision is its emphasis on selecting outcome measures that can reliably detect meaningful clinical changes, rather than relying exclusively on statistically significant treatment effects.
Prevalence and Incidence
A systematic review cited in the CPG estimates global CTS prevalence at approximately 14.4%, with higher estimates in high-income countries (16.9%) than low- and middle-income countries (11.4%). CTS is more common in women, and occupational incidence varies with physical hand-loading demands. The guideline reports that US workers in labor-intensive jobs had substantially higher CTS incidence than clerical workers.
Pathogenesis and Risk Factors
Increased pressure within the carpal tunnel can impair median nerve perfusion, causing ischemia and intraneural edema; persistent changes may contribute to fibrosis in the nerve or surrounding tissues. The CPG also discusses inflammatory processes and altered median nerve morphology on ultrasound.
Obesity, increasing age, and female sex are among the strongest intrinsic risk factors. Forceful hand exertion is the most consistently supported occupational factor; high overall exposure to force, repetition, and demanding wrist movements may increase risk. Prolonged non-neutral wrist positions and vibratory tools have conflicting updated evidence, while computer use is not supported as an independent risk factor by the newer evidence. For education, clinicians can discuss symptom-provoking tasks and wrist positions with patients, but should not present every suspected exposure as an established cause.
Clinical Course
Typical symptoms include nocturnal numbness, tingling, or pain in the median nerve distribution, sometimes accompanied by dropping objects. Progression may involve thenar weakness, muscle wasting, and impaired thumb abduction or opposition. The guideline distinguishes acute presentations, which can follow trauma or acute inflammation, from the more common gradual-onset course. It also highlights the possible contribution of neuropathic pain, psychosocial factors, and altered pain processing to persistent symptoms.
Evidence Grades Explained
Each recommendation is assigned an evidence grade reflecting the quality and consistency of the supporting research:
- Grade A – Strong evidence: Supported by high-quality research providing substantial confidence in the recommendation.
- Grade B – Moderate evidence: Supported by moderately strong clinical research, including high-quality individual studies.
- Grade C – Weak evidence: Supported by a limited body of research or studies with methodological limitations.
- Grade D – Conflicting evidence: Available studies provide inconsistent findings, preventing a clear recommendation.
- Grade E – Theoretical/foundational evidence: Based primarily on basic science, biomechanical principles, or other foundational research.
- Grade F – Expert opinion: Based on clinical expertise and consensus when direct research evidence is insufficient.
Importantly, the strength of evidence does not necessarily indicate the magnitude of a treatment’s effect, and a Grade A recommendation may also advise against an intervention.
Key Clinical Recommendations
1. Assessment & Diagnosis
Symptom Distribution and Clinical History
Clinicians should use the Katz and Stirrat hand symptom diagram to identify the location and characteristics of symptoms in individuals with suspected CTS (Grade B). The diagram helps establish whether symptoms follow a distribution consistent with median nerve involvement and provides additional information to support clinical diagnosis.
For suspected work-related CTS, the Katz and Stirrat diagram or Kamath and Stothard questionnaire may also be used as initial screening tools (Grade C).
Provocative Tests:
Clinicians should use the following tests to assist in diagnosing suspected CTS:
Phalen test (Grade B)
Tinel sign (Grade B)
Carpal compression (Durkan) test (Grade B)
These tests provide useful diagnostic information but should not be interpreted independently. The outcomes should be considered in the context of all clinical findings. No single provocative test has sufficient diagnostic accuracy to confirm or exclude CTS in isolation.
Sensory and Motor Assessment:
The guideline emphasizes standardized sensory examination:
- Semmes-Weinstein monofilaments (Grade A): Recommended for assessing sensory detection thresholds.
- Static two-point discrimination (Grade B): Recommended for assessing spatial sensory discrimination.
- Grip and tip/tripod pinch strength (Grade C): May be assessed alongside hand function using the Purdue Pegboard or Dellon-modified Moberg pick-up test.
- Thenar muscle examination (Grade F): May be performed to identify muscle atrophy associated with more advanced median nerve dysfunction.
Combination Testing (Grade B):
Clinicians should use the Carpal Tunnel Syndrome-6 (CTS-6) to help diagnose individuals with suspected CTS. This clinical scoring system combines findings from the history and physical examination, hence, it offers a more comprehensive approach than relying on isolated provocative tests.
Electrodiagnostic testing can assess myelinated nerve function, including focal demyelination and axonal loss, while diagnostic ultrasound can identify median nerve enlargement and anatomical variations. The guideline notes that additional testing should be considered in light of its cost and whether the results are likely to change management, such as prompting surgical referral.
Classification of CTS Severity:
CTS is commonly classified as mild, moderate, or severe. However, clinical signs and symptoms alone cannot reliably determine its severity. Although thenar muscle atrophy is commonly associated with severe CTS, electrodiagnostic testing may provide additional information about nerve involvement. Several electrodiagnostic grading systems are available, but there is currently no consensus on a preferred classification system.
2. Outcome Measures
The 2026 guideline places particular emphasis on selecting outcome measures with demonstrated responsiveness to clinical change.
Symptom Severity and Function (Grade B):
Clinicians should use:
- Boston Carpal Tunnel Questionnaire – Symptom Severity Scale (BCTQ-SSS): To assess changes in symptom severity.
- DASH or QuickDASH: To evaluate changes in upper-limb function.
These measures should be collected at baseline and at least one follow-up assessment, including discharge.
Alternative Functional Measures (Grade C):
The Boston Carpal Tunnel Questionnaire – Functional Status Scale (BCTQ-FSS) may be used when DASH or QuickDASH is unavailable.
PROMIS Pain Interference, PROMIS Upper Extremity, and the Dellon-modified Moberg pick-up test may also be considered for monitoring function in surgically managed CTS.
Strength Testing as an Outcome Measure:
The guideline makes two important recommendations against commonly used measures:
- Lateral pinch strength (Grade A): Should not be used to assess change in individuals with nonsurgically or surgically managed CTS.
- Grip strength (Grade B): Should not be used to assess short-term changes (less than three months) following surgery.
These recommendations concern the ability of these measurements to detect change, rather than their potential usefulness when evaluating baseline impairment.
3. Rehabilitation Principles
Wrist Orthoses (Grade B):
Clinicians should recommend a forearm-based wrist immobilization orthosis that maintains the wrist close to neutral in the sagittal plane. Night-time use is recommended for short- and medium-term improvements in symptoms and function in individuals with mild to moderate CTS, including those awaiting surgery.
If night-time splinting provides insufficient relief, clinicians may consider:
- Daytime, symptom-dependent, or full-time orthosis use.
- Modifying wrist positioning.
- Adding metacarpophalangeal joint immobilization.
These modifications carry Grade C recommendations.
For pregnancy-related CTS, clinicians may recommend an orthosis and arrange postpartum follow-up to assess symptom resolution (Grade C).
Patient Education and Ergonomic Advice (Grades C–F):
Education should address symptom management, potentially aggravating activities, and modifiable risk factors.
Clinicians may advise individuals on alternative computer-input strategies, including reduced-force keyboards, touch screens, arrow keys, or alternating mouse use (Grade C).
More broadly, clinicians may explain CTS pathology, discuss potentially contributing wrist and hand positions, and collaboratively identify ways to modify aggravating activities (Grade F).
These recommendations support individualized activity modification rather than indiscriminate avoidance of hand use.
Manual Therapy (Grade C):
Clinicians may perform manual therapy directed toward the cervical spine and upper extremity, particularly at potential sites of median nerve entrapment, to achieve short-term improvements in pain and function in individuals with mild to moderate CTS. Instrument-assisted soft tissue techniques, specifically diacutaneous fibrolysis, may also provide short-term improvements in symptoms and function. However, the evidence does not establish these interventions as superior long-term treatments, and their role should be considered within a broader management plan.
Therapeutic Exercise (Grade C):
Clinicians may use a combined orthotic and stretching program for individuals with mild to moderate CTS who demonstrate:
- No thenar muscle atrophy.
- Normal two-point discrimination.
Evidence regarding isolated tendon-gliding and neural mobilization exercises remains less conclusive. The guideline identifies conflicting findings for neurodynamic mobilization, which prevents a clear recommendation for its routine use.
Kinesiology Taping (Grade C):
Kinesiology taping may be used for short- and medium-term symptom improvement in individuals with mild CTS. Although this represents an additional conservative treatment option, the evidence does not establish taping as a replacement for wrist orthoses.
4. Adjunct Modalities
Laser Therapy (Grade C):
Low-level laser therapy and high-intensity laser therapy may be considered for short-term improvements in pain and function in individuals with mild to moderate CTS.
Extracorporeal Shock Wave Therapy (Grade C):
Clinicians may use extracorporeal shock wave therapy (ESWT) to improve symptoms and function in the short and medium term (less than six months). The guideline suggests considering radial ESWT over focused ESWT.
Interferential Current (Grade C):
Interferential current may be used for short-term pain relief in individuals with mild to moderate CTS.
Superficial Heat and Diathermy (Grade C):
Superficial heat may provide short-term symptom improvement.
Microwave or shortwave diathermy may also be considered for short-term symptom relief in individuals with mild to moderate CTS.
Iontophoresis and Phonophoresis (Grade A):
Clinicians should NOT use corticosteroid iontophoresis or phonophoresis for nonsurgical management of CTS. The guideline reports no high-quality evidence demonstrating the efficacy of transdermal drug delivery for CTS. Comparisons of phonophoresis with other interventions generally found no clear difference, while substantial variation in drugs, dosage, treatment frequency, and duration limits interpretation.
Magnet Therapy (Grade B):
Clinicians should NOT use or recommend magnets for CTS management. These negative recommendations are clinically important, particularly when deciding whether the potential benefits of adjunct modalities justify their cost, time, and treatment burden.
5. Monitoring Progression and Clinical Decision-Making
The guideline does not establish a standardized progression or return-to-work protocol. Nevertheless, its recommendations support an impairment- and outcome-based approach to monitoring recovery.
- Clinicians should consider:
- Changes in symptom severity using the BCTQ-SSS.
- Improvements in functional ability using DASH or QuickDASH.
- Sensory findings and evidence of motor impairment.
- Tolerance of occupational and daily activities.
- Response to orthotic management and activity modification.
Individuals with progressive sensory loss, increasing weakness, or thenar atrophy require particular attention, as these findings may indicate more advanced median nerve dysfunction and warrant further medical evaluation.
Online Course
Build confidence in assessing and treating shoulder, elbow, wrist, and hand conditions with practical, evidence-based rehabilitation strategies.
Summary
The 2026 CTS CPG reinforces the importance of structured clinical assessment, validated outcome measures, and individualized conservative management.
Wrist orthoses remain a central recommendation for mild to moderate CTS, while education, manual therapy, exercise, taping, and selected adjunct modalities may offer additional benefits depending on clinical presentation.
However, the guideline also highlights substantial differences in evidence quality between interventions and cautions against assuming that short-term symptom improvement translates into sustained recovery.
Changes from the 2019 Guideline
- Expanded diagnostic assessment: Updated evidence supports the CTS-6 as a recommended combination diagnostic tool.
- Greater emphasis on sensory testing: Semmes-Weinstein monofilaments receive a Grade A recommendation, while static two-point discrimination is supported by Grade B evidence.
- More specific outcome measure recommendations: The BCTQ-SSS and DASH/QuickDASH are emphasized for tracking meaningful changes in symptoms and function.
- Recommendations against selected strength measures: Lateral pinch strength should not be used to monitor change, while grip strength is discouraged for assessing short-term postoperative outcomes.
- Updated orthosis recommendations: Greater detail is provided regarding wrist positioning, wear schedules, and modifications when night-time use is insufficient.
- Manual therapy evidence updated: New studies support selected techniques for short-term improvements, although recommendations remain relatively weak.
- Neural mobilization evidence reconsidered: Conflicting findings prevent a clear recommendation for routine use.
- New interventions evaluated: ESWT, kinesiology taping, dry needling, and topical agents are addressed in the revised guideline.
- ESWT and taping added as treatment options: Both receive Grade C recommendations for selected patients.
- Clear recommendations against certain modalities: Corticosteroid iontophoresis and phonophoresis receive Grade A recommendations against use, while magnet therapy is discouraged with Grade B evidence.
Limitations & Conclusion
Despite incorporating substantial new research, the 2026 guideline identifies important limitations in the evidence for conservative CTS management.
Many intervention studies combine several treatments, making it difficult to determine the independent effects of individual techniques. Variability in orthosis design, treatment dosage, and comparator interventions further complicates interpretation.
Evidence for several adjunct modalities remains limited to short-term outcomes, and conflicting results persist for neural mobilization. Additional high-quality trials are needed to establish the effectiveness of emerging interventions such as dry needling and to determine which patients are most likely to benefit from specific treatment approaches.
Importantly, the guideline primarily addresses nonsurgical management of mild to moderate CTS. Its treatment recommendations should therefore not be automatically extrapolated to patients with severe neurological impairment or those recovering from carpal tunnel release surgery.
As emphasized in the guideline’s statement of intent, recommendations are intended to inform rather than replace clinical reasoning. Treatment decisions should integrate the available evidence with symptom severity, neurological findings, patient preferences, and functional demands.
Finally, the 2026 CTS CPG provides an updated framework for physiotherapists that prioritizes accurate clinical assessment, meaningful outcome tracking, and appropriately selected conservative interventions, and encourages a critical approach to treatments supported primarily by short-term or low-certainty evidence.
Reference
Erickson, M., et al. (2026). Hand pain and sensory deficits: Carpal tunnel syndrome: Revision 2026. Journal of Orthopaedic & Sports Physical Therapy, 56(4), CPG1–CPG79. https://doi.org/10.2519/jospt.2026.0301
